ResMed Inc. (RMD)
NYSE · Common stock · Surgical & Medical Instruments & Apparatus
As of Oct 21, 12:24 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow RMD in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on RMD and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
RMD at a glance
Key statistics
$34.53B
Market capitalization
- Previous close
- $245.50
- Open
- $244.93
- Day range
- $244.40 – $248.16
- Volume
- 270.2K
- Average volume (30 sessions)
- 1.18M
- Shares outstanding
- 140.64M
- Price / earnings
- 22.7
- Earnings per share
- $10.83
- Price / book
- 5.2
- Price / sales
- 6.1
- Dividend yield
- 1.01%
- Beta (1 year, vs SPY)
- 0.40
Where the price sits in its year
52-week range
68% of the range
- Below the 52-week high
- -11.2%
- Above the 52-week low
- +36.8%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $228.50+7.4%
- 50-day average
- $228.04+7.7%
- 200-day average
- $225.03+9.1%
In the band above 70 that convention calls overbought. Strong trends can stay there for weeks.
+4.5%
1 week
+9.8%
1 month
+27.3%
3 months
+1.9%
Year to date
-8.4%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with RMD
RMD on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on RMD.
See the plans →
Every planScreen names like RMD
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on RMD
Put RMD on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on RMD
See whether there is an open premium alert on RMD, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
RMD headlines
- 23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
GlobeNewswire Inc. · Aug 25, 2026
- Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
Benzinga · Jun 3, 2026
- Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - ResMed, Koninklijke Philips, and Carefusion
GlobeNewswire Inc. · Apr 29, 2026
- Saudi Arabia $5.94 Bn Sleep Apnea Devices Market Trends, Competition, Forecast & Opportunities, 2030F Featuring ResMed, Philips, Invacare, Itamar Medical, and Nihon Kohden
GlobeNewswire Inc. · Oct 7, 2025
- ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast
Benzinga · Apr 24, 2025
- Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
Benzinga · Apr 23, 2025
- Resmed Names Salli Schwartz as Chief Investor Relations Officer
GlobeNewswire Inc. · Apr 21, 2025
- Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst
Benzinga · Oct 25, 2024
SEC Form 4, most recent first
Insider filings
Farrell Michael J.
−5.0K
Chairman and CEO, Director · Option exercise
· Oct 7, 2026
Farrell Michael J.
+5.0K
Chairman and CEO, Director · Option exercise
$730.38K · Oct 7, 2026
Farrell Michael J.
−5.0K
Chairman and CEO, Director · Open-market sale
$1.13M · Oct 7, 2026
Rider Michael J
+3.2K
Global General Counsel · Grant or award
· Aug 14, 2026
Leong Justin
+6.5K
Chief Product Officer · Grant or award
· Aug 14, 2026
Bloomer Aaron
+9.1K
Chief Financial Officer · Grant or award
· Aug 14, 2026
Farrell Michael J.
+13.5K
Chairman and CEO, Director · Grant or award
· Aug 14, 2026
Farrell Michael J.
−5.0K
Chairman and CEO, Director · Option exercise
· Sep 8, 2026
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- San Diego, CA
- Employees
- 11,370
- Listed since
- Jun 2, 1995
- Website
- resmed.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.